Abstract
Cancer cells are distinguished from each other and from healthy cells by features that drive clonal evolution and therapy resistance. New advances in high-dimensional flow cytometry make it possible to systematically measure mechanisms of tumor initiation, progression, and therapy resistance on millions of cells from human tumors. Here we describe flow cytometry techniques that enable a “single-cell ” view of cancer. High-dimensional techniques like mass cytometry enable multiplexed single-cell analysis of cell identity, clinical biomarkers, signaling network phospho-proteins, transcription factors, and functional readouts of proliferation, cell cycle status, and apoptosis. This capability pairs well with a signaling profiles approach that dissects mechanism by systematically perturbing and measuring many nodes in a signaling network. Single-cell approaches enable study of cellular heterogeneity of primary tissues and turn cell subsets into experimental controls or opportunities for new discovery. Rare populations of stem cells or therapy-resistant cancer cells can be identified and compared to other types of cells within the same sample. In the long term, these techniques will enable tracking of minimal residual disease (MRD) and disease progression. By better understanding biological systems that control development and cell–cell interactions in healthy and diseased contexts, we can learn to program cells to become therapeutic agents or target malignant signaling events to specifically kill cancer cells. Single-cell approaches that provide deep insight into cell signaling and fate decisions will be critical to optimizing the next generation of cancer treatments combining targeted approaches and immunotherapy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aghaeepour N, Finak G, Flow CAPC, Consortium D, Hoos H, Mosmann TR et al (2013) Critical assessment of automated flow cytometry data analysis techniques. Nat Methods 10:228–238
el Amir AD, Davis KL, Tadmor MD, Simonds EF, Levine JH, Bendall SC et al (2013) viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat Biotechnol 31:545–552
Andreeff M, Slater DE, Bressler J, Furth ME (1986) Cellular RAS oncogene expression and cell cycle measured by flow cytometry in hematopoietic cell lines. Blood 67:676–681
Armstrong JS, Steinauer KK, Hornung B, Irish JM, Lecane P, Birrell GW et al (2002) Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line. Cell Death Differ 9:252–263
Baerlocher GM, Vulto I, de Jong G, Lansdorp PM (2006) Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat Protoc 1:2365–2376
Barcellos-Hoff MH, Lyden D, Wang TC (2013) The evolution of the cancer niche during multistage carcinogenesis. Nat Rev Cancer 13:511–518
Behbehani GK, Bendall SC, Clutter MR, Fantl WJ, Nolan GP (2012) Single-cell mass cytometry adapted to measurements of the cell cycle. Cytometry A 81:552–566
Belloc F, Belaud-Rotureau MA, Lavignolle V, Bascans E, Braz-Pereira E, Durrieu F et al (2000) Flow cytometry detection of caspase 3 activation in preapoptotic leukemic cells. Cytometry 40:151–160
Bendall SC, Nolan GP (2012) From single cells to deep phenotypes in cancer. Nat Biotechnol 30:639–647
Bendall SC, Nolan GP, Roederer M, Chattopadhyay PK (2012) A deep profiler’s guide to cytometry. Trends Immunol 33:323–332
Bendall SC, Simonds EF, Qiu P, el Amir AD, Krutzik PO, Finck R et al (2011) Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332:687–696
Bodenmiller B, Zunder ER, Finck R, Chen TJ, Savig ES, Bruggner RV et al (2012) Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators. Nat Biotechnol 30:858–867
Bourton EC, Plowman PN, Zahir SA, Senguloglu GU, Serrai H, Bottley G et al (2012) Multispectral imaging flow cytometry reveals distinct frequencies of gamma-H2AX foci induction in DNA double strand break repair defective human cell lines. Cytometry A 81:130–137
Byrd JC, Furman RR, Coutre SE, Flinn IW, Burger JA, Blum KA et al (2013) Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med 369:32–42
Carney WP, Petit D, Hamer P, Der CJ, Finkel T, Cooper GM et al (1986) Monoclonal antibody specific for an activated RAS protein. Proc Nat Acad Sci USA 83:7485–7489
Castillo R, Mascarenhas J, Telford W, Chadburn A, Friedman SM, Schattner EJ (2000) Proliferative response of mantle cell lymphoma cells stimulated by CD40 ligation and IL-4. Leukemia 14:292–298
Chow S, Hedley D (1995) Flow cytometric determination of glutathione in clinical samples. Cytometry 21:68–71
Cooperman J, Neely R, Teachey DT, Grupp S, Choi JK (2004) Cell division rates of primary human precursor B cells in culture reflect in vivo rates. Stem Cells 22:1111–1120
Dalerba P, Kalisky T, Sahoo D, Rajendran PS, Rothenberg ME, Leyrat AA et al (2011) Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat Biotechnol 29:1120–1127
Dickinson BC, Chang CJ (2008) A targetable fluorescent probe for imaging hydrogen peroxide in the mitochondria of living cells. J Am Chem Soc 130:9638–9639
Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS (1991) Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 77:925–929
Erlanson M, Landberg G (1998) Flow cytometric quantification of cyclin E in human cell lines and hematopoietic malignancies. Cytometry 32:214–222
Fienberg HG, Simonds EF, Fantl WJ, Nolan GP, Bodenmiller B (2012) A platinum-based covalent viability reagent for single-cell mass cytometry. Cytometry A 81:467–475
Flotho C, Kratz C, Niemeyer CM (2007) Targeting RAS signaling pathways in juvenile myelomonocytic leukemia. Curr Drug Targets 8:715–725
Gerdes MJ, Sevinsky CJ, Sood A, Adak S, Bello MO, Bordwell A et al (2013) Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue. Proc Nat Acad Sci USA 110:11982–11987
Gerner MY, Kastenmuller W, Ifrim I, Kabat J, Germain RN (2012) Histo-cytometry: a method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes. Immunity 37:364–376
Green MR, Gentles AJ, Nair RV, Irish JM, Kihira S, Liu CL et al (2013) Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood 121:1604–1611
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Hasegawa D, Bugarin C, Giordan M, Bresolin S, Longoni D, Micalizzi C et al (2013) Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia. Blood Cancer J 3:e160
Holyoake T, Jiang X, Eaves C, Eaves A (1999) Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood 94:2056–2064
Huang X, Traganos F, Darzynkiewicz Z (2003) DNA damage induced by DNA topoisomerase I- and topoisomerase II-inhibitors detected by histone H2AX phosphorylation in relation to the cell cycle phase and apoptosis. Cell Cycle 2:614–619
Irish J, Hovland R, Krutzik P, Perez O, Bruserud O, Gjertsen B et al (2004) Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118:217–228
Irish J, Kotecha N, Nolan G (2006a) Innovation–mapping normal and cancer cell signalling networks: towards single-cell proteomics. Nat Rev Cancer 6:146–155
Irish JM, Czerwinski DK, Nolan GP, Levy R (2006b) Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma. B cells from tumor-infiltrating nonmalignant B cells. Blood 108:3135–3142
Irish JM, Anensen N, Hovland R, Skavland J, Borresen-Dale A-L, Bruserud O et al (2007) Flt3 Y591 duplication and Bc1-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53. Blood 109:2589–2596
Irish JM, Myklebust JH, Alizadeh AA, Houot R, Sharman JP, Czerwinski DK et al (2010) B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression. Proc Nat Acad Sci USA 107:12747–12754
Juan G, Traganos F, James WM, Ray JM, Roberge M, Sauve DM et al (1998) Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. Cytometry 32:71–77
Kalisky T, Quake SR (2011) Single-cell genomics. Nat Methods 8:311–314
Kotecha N, Floress NJ, Irish JM, Simonds EF, Sakai DS, Archambeault S et al (2008) Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell 14:335–343
Krutzik PO, Crane JM, Clutter MR, Nolan GP (2008) High-content single-cell drug screening with phosphospecific flow cytometry. Nat Chem Biol 4:132–142
Krutzik PO, Hale MB, Nolan GP (2005) Characterization of the murine immunological signaling network with phosphospecific flow cytometry. J Immunol 175:2366–2373
Krutzik PO, Irish JM, Nolan GP, Perez OD (2004) Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. Clin Immunol 110:206–221
Krutzik PO, Nolan GP (2006) Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat Methods 3:361–368
Krutzik PO, Nolan GP (2003) Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry A 55:61–70
Laane E, Tani E, Bjorklund E, Elmberger G, Everaus H, Skoog L et al (2005) Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin’s lymphoma. Cytometry B Clin Cytometry 64:34–42
Lee PP, Yee C, Savage PA, Fong L, Brockstedt D, Weber JS et al (1999) Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 5:677–685
Maecker HT, Levy R (1989) Prevalence of antigen receptor variants in human T cell lines and tumors. J Immunol 142:1395–1404
Maecker HT, Trotter J (2006) Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A 69:1037–1042
Marcy Y, Ouverney C, Bik EM, Losekann T, Ivanova N, Martin HG et al (2007) Dissecting biological “dark matter” with single-cell genetic analysis of rare and uncultivated TM7 microbes from the human mouth. Proc Nat Acad Sci USA 104:11889–11894
Mason D, Andre P, Bensussan A, Buckley C, Civin C, Clark E et al (2002) CD antigens 2002. Blood 99:3877–3880
Mayle A, Luo M, Jeong M, Goodell MA (2013) Flow cytometry analysis of murine hematopoietic stem cells. Cytometry A 83:27–37
Morkve O, Halvorsen OJ, Stangeland L, Gulsvik A, Laerum OD (1992) Quantitation of biological tumor markers (p53, c-myc, Ki-67 and DNA ploidy) by multiparameter flow cytometry in non-small-cell lung cancer. Int J Cancer 52:851–855
Myklebust JH, Irish JM, Brody J, Czerwinski DK, Houot R, Kohrt HE et al (2013) High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells. Blood 121:1367–1376
Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271–279
O’Brien MC, Bolton WE (1995) Comparison of cell viability probes compatible with fixation and permeabilization for combined surface and intracellular staining in flow cytometry. Cytometry 19:243–255
Ohtani S, Kagawa S, Tango Y, Umeoka T, Tokunaga N, Tsunemitsu Y et al (2004) Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo. Mol Cancer Ther 3:93–100
Ornatsky OI, Lou X, Nitz M, Schafer S, Sheldrick WS, Baranov VI et al (2008) Study of cell antigens and intracellular DNA by identification of element-containing labels and metallointercalators using inductively coupled plasma mass spectrometry. Anal Chem 80:2539–2547
Panoskaltsis N, Reid CD, Knight SC (2003) Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia. Leukemia 17:716–730
Perfetto SP, Chattopadhyay PK, Roederer M (2004) Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol 4:648–655
Powell AA, Talasaz AH, Zhang H, Coram MA, Reddy A, Deng G et al (2012) Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS One 7:e33788
Pyne S, Hu X, Wang K, Rossin E, Lin TI, Maier LM et al (2009) Automated high-dimensional flow cytometric data analysis. Proc Nat Acad Sci USA 106:8519–8524
Qiu P, Simonds EF, Bendall SC, Gibbs KD Jr, Bruggner RV, Linderman MD et al (2011) Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat Biotechnol 29:886–891
Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105–111
Rickert RC (2013) New insights into pre-BCR and BCR signalling with relevance to B cell malignancies. Nat Rev Immunol 13:578–591
Robillard N, Pellat-Deceunynck C, Bataille R (2005) Phenotypic characterization of the human myeloma cell growth fraction. Blood 105:4845–4848
Sachen KL, Strohman MJ, Singletary J, Alizadeh AA, Kattah NH, Lossos C et al (2012) Self-antigen recognition by follicular lymphoma B-cell receptors. Blood 120:4182–4190
Sachs K, Perez O, Pe’er D, Lauffenburger DA, Nolan GP (2005) Causal protein-signaling networks derived from multiparameter single-cell data. Science 308:523–529
Schmid I, Krall WJ, Uittenbogaart CH, Braun J, Giorgi JV (1992) Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 13:204–208
Schnitt SJ (2010) Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. Mod Pathol 23(Suppl 2):S60–S64
Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182:311–322
Timmerman JM, Czerwinski DK, Davis TA, Hsu FJ, Benike C, Hao ZM et al (2002) Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. Blood 99:1517–1526
Trentin L, Cabrelle A, Facco M, Carollo D, Miorin M, Tosoni A et al (2004) Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. Blood 104:502–508
van Dongen JJ, Lhermitte L, Bottcher S, Almeida J, van der Velden VH, Flores-Montero J et al (2012) EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia 26:1908–1975
Van Meter MEM, Diaz-Flores E, Archard JA, Passegue E, Irish JM, Kotecha N et al (2007) K-Ras(G12D) expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cells. Blood 109:3945–3952
Wang ML, Rule S, Martin P, Goy A, Auer R, Kahl BS et al (2013) Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N Engl J Med 369:507–516
Wozniak J, Kopec-Szlezak J (2004) c-Kit receptor (CD117) expression on myeloblasts and white blood cell counts in acute myeloid leukemia. Cytometry B Clin Cytometry 58:9–16
Wu AR, Neff NF, Kalisky T, Dalerba P, Treutlein B, Rothenberg ME et al (2014) Quantitative assessment of single-cell RNA-sequencing methods. Nat Methods 11:41–46
Zheng A, Castren K, Saily M, Savolainen ER, Koistinen P, Vahakangas K (1999) p53 status of newly established acute myeloid leukaemia cell lines. Br J Cancer 79:407–415
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Irish, J.M., Doxie, D.B. (2014). High-Dimensional Single-Cell Cancer Biology. In: Fienberg, H., Nolan, G. (eds) High-Dimensional Single Cell Analysis. Current Topics in Microbiology and Immunology, vol 377. Springer, Berlin, Heidelberg. https://doi.org/10.1007/82_2014_367
Download citation
DOI: https://doi.org/10.1007/82_2014_367
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54826-0
Online ISBN: 978-3-642-54827-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)